Literature DB >> 20194862

Neutrophil count in African Americans: lowering the target cutoff to initiate or resume chemotherapy?

Matthew M Hsieh1, John F Tisdale, Griffin P Rodgers, Neal S Young, Edward L Trimble, Richard F Little.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20194862      PMCID： PMC2849762          DOI： 10.1200/JCO.2009.24.3881

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  49 in total

1.  Investigation of the effect of marathon running on leucocyte counts of subjects of different ethnic origins: relevance to the aetiology of ethnic neutropenia.

Authors:  B J Bain; D Phillips; K Thomson; D Richardson; I Gabriel
Journal:  Br J Haematol       Date:  2000-03       Impact factor: 6.998

2.  Investigation of ethnic neutropenia by assessment of bone marrow colony-forming cells.

Authors:  K Rezvani; A M Flanagan; U Sarma; N Constantinovici; B J Bain
Journal:  Acta Haematol       Date:  2001       Impact factor: 2.195

3.  Mobilization, collection, and processing of peripheral blood stem cells in individuals with sickle cell trait.

Authors:  Elizabeth M Kang; Ellen M Areman; Virginia David-Ocampo; Courtney Fitzhugh; Mary E Link; Elizabeth J Read; Susan F Leitman; Griffin P Rodgers; John F Tisdale
Journal:  Blood       Date:  2002-02-01       Impact factor: 22.113

4.  Evidence that the number of hematopoietic stem cells per animal is conserved in mammals.

Authors:  Janis L Abkowitz; Sandra N Catlin; Monica T McCallie; Peter Guttorp
Journal:  Blood       Date:  2002-10-01       Impact factor: 22.113

5.  Ethnic neutropenia and treatment delay in African American women undergoing chemotherapy for early-stage breast cancer.

Authors:  Dawn Hershman; Mitchell Weinberg; Zachary Rosner; Karenza Alexis; Amy Tiersten; Victor R Grann; Andrea Troxel; Alfred I Neugut
Journal:  J Natl Cancer Inst       Date:  2003-10-15       Impact factor: 13.506

6.  Racial diversity with high nucleated cell counts and CD34 counts achieved in a national network of cord blood banks.

Authors:  Karen K Ballen; Joanne Kurtzberg; Thomas A Lane; Bruce R Lindgren; John P Miller; Denis Nagan; Bruce Newman; Neil Rupp; N Rebecca Haley
Journal:  Biol Blood Marrow Transplant       Date:  2004-04       Impact factor: 5.742

7.  Selection and description of cancer clinical trials participants--science or happenstance?

Authors:  G Marie Swanson; John C Bailar
Journal:  Cancer       Date:  2002-09-01       Impact factor: 6.860

8.  Enrollment of African Americans onto clinical treatment trials: study design barriers.

Authors:  Lucile L Adams-Campbell; Chiledum Ahaghotu; Melvin Gaskins; Fitzroy W Dawkins; Duane Smoot; Octavius D Polk; Robert Gooding; Robert L DeWitty
Journal:  J Clin Oncol       Date:  2004-02-15       Impact factor: 44.544

9.  Racial disparity in the dose and dose intensity of breast cancer adjuvant chemotherapy.

Authors:  Jennifer J Griggs; Melony E S Sorbero; Azadeh T Stark; Susanne E Heininger; Andrew W Dick
Journal:  Breast Cancer Res Treat       Date:  2003-09       Impact factor: 4.872

10.  First-cycle blood counts and subsequent neutropenia, dose reduction, or delay in early-stage breast cancer therapy.

Authors:  J H Silber; M Fridman; R S DiPaola; M H Erder; M V Pauly; K R Fox
Journal:  J Clin Oncol       Date:  1998-07       Impact factor: 44.544
View more
  25 in total

1.  Infection-related complications during treatment for childhood acute lymphoblastic leukemia.

Authors:  H Inaba; D Pei; J Wolf; S C Howard; R T Hayden; M Go; O Varechtchouk; T Hahn; J Buaboonnam; M L Metzger; J E Rubnitz; R C Ribeiro; J T Sandlund; S Jeha; C Cheng; W E Evans; M V Relling; C-H Pui
Journal:  Ann Oncol       Date:  2017-02-01       Impact factor: 32.976

2.  Evaluation of the Safety of Clozapine Use in Patients With Benign Neutropenia.

Authors:  Charles M Richardson; Erica A Davis; Gopal R Vyas; Bethany A DiPaula; Robert P McMahon; Deanna L Kelly
Journal:  J Clin Psychiatry       Date:  2016-11       Impact factor: 4.384

3.  Phase II study of bevacizumab in patients with HIV-associated Kaposi's sarcoma receiving antiretroviral therapy.

Authors:  Thomas S Uldrick; Kathleen M Wyvill; Pallavi Kumar; Deirdre O'Mahony; Wendy Bernstein; Karen Aleman; Mark N Polizzotto; Seth M Steinberg; Stefania Pittaluga; Vickie Marshall; Denise Whitby; Richard F Little; Robert Yarchoan
Journal:  J Clin Oncol       Date:  2012-03-19       Impact factor: 44.544

Review 4.  The genomic landscape of African populations in health and disease.

Authors:  Charles N Rotimi; Amy R Bentley; Ayo P Doumatey; Guanjie Chen; Daniel Shriner; Adebowale Adeyemo
Journal:  Hum Mol Genet       Date:  2017-10-01       Impact factor: 6.150

5.  Lower Total Leukocyte and Neutrophil Counts in Healthy Young Africans from Uganda.

Authors:  Ritesh Goswami; Naveen Kakkar; M Joseph John
Journal:  Indian J Hematol Blood Transfus       Date:  2017-08-23       Impact factor: 0.900

6.  Laboratory Eligibility Criteria as Potential Barriers to Participation by Black Men in Prostate Cancer Clinical Trials.

Authors:  Marie E Vastola; David D Yang; Vinayak Muralidhar; Brandon A Mahal; Christopher S Lathan; Bradley A McGregor; Paul L Nguyen
Journal:  JAMA Oncol       Date:  2018-03-01       Impact factor: 31.777

7.  Risk of a second breast cancer associated with hormone-receptor and HER2/neu status of the first breast cancer.

Authors:  Leona Bessonova; Thomas H Taylor; Rita S Mehta; Jason A Zell; Hoda Anton-Culver
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-01-07       Impact factor: 4.254

8.  Molecular response to imatinib in patients with chronic myeloid leukemia in Tanzania.

Authors:  Ahlam Nasser; Ally Hussein; Clara Chamba; Mbonea Yonazi; Rosemary Mushi; Anna Schuh; Lucio Luzzatto
Journal:  Blood Adv       Date:  2021-03-09

Review 9.  Benign ethnic neutropenia.

Authors:  Suheil Albert Atallah-Yunes; Audrey Ready; Peter E Newburger
Journal:  Blood Rev       Date:  2019-06-21       Impact factor: 8.250

10.  Race and ethnicity influences collection of granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells from unrelated donors, a Center for International Blood and Marrow Transplant Research analysis.

Authors:  Jack W Hsu; John R Wingard; Brent R Logan; Pintip Chitphakdithai; Gorgun Akpek; Paolo Anderlini; Andrew S Artz; Chris Bredeson; Steven Goldstein; Gregory Hale; Peiman Hematti; Sarita Joshi; Rammurti T Kamble; Hillard M Lazarus; Paul V O'Donnell; Michael A Pulsipher; Bipin N Savani; Raquel M Schears; Bronwen E Shaw; Dennis L Confer
Journal:  Biol Blood Marrow Transplant       Date:  2014-10-12       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.